USPTO serial 99260614
ULTRACELL
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with ULTRACELL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Evanston, IL, US
Evanston, IL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert T. Maldonado
Robert T. Maldonado Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | plasmid kits comprising DNA buffers for research use, nucleotide sequences for research use, and viral vectors for research use; viral vectors for research purposes, namely, virus-like particle vector preparations for use in gene therapy and medical and scientific research; pharmaceutical and biological preparations, namely, viral vectors for use in the manufacture of pharmaceuticals and biological preparations for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | pharmaceutical and biological preparations, namely, biological reagents, including nucleotide sequences, viral vectors, and plasmid kits comprising DNA buffers, nucleotide sequences, and viral vectors, all for medical use | ACTIVE | — |
| 040 | manufacturing of pharmaceuticals and biopharmaceuticals for others | ACTIVE | — |
| 042 | pharmaceutical and biopharmaceutical scientific research and development services using engineered viral vectors; product development for others relating to pharmaceuticals and biopharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Syenex, Inc.
- Other trademarks owned by Syenex, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ULTRACELL
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 5, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 10, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 12, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 12, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 12, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 12, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 5, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 30, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 30, 2025 | NWAP | NEW APPLICATION ENTERED | — |